Clinical Trials Directory

Trials / Unknown

UnknownNCT03282110

Comprehensive Acupuncture for Depressive Disorder With Comorbid Psychogenic Pain

Comprehensive Acupuncture for Depressive Disorder With Comorbid Psychogenic Pain: Randomized Controlled Study

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Experimental and clinical studies have indicated that acupuncture has a good effect for depression and comorbid pain. The purpose of this research is to compare the effect of comprehensive electro-acupuncture therapy and western medicine citalopram for for depressive disorder with comorbid psychogenic pain. This research is a assessor blinded, randomized controlled trials. 60 patients will be randomly divided into comprehensive electro-acupuncture group and western medicine citalopram for 8 weeks treatment and the therapeutic effect is done at the end of 1,2,4,6,8 week.

Conditions

Interventions

TypeNameDescription
DEVICEta-VNSThe transcutaneous vagus nerve stimulation (taVNS) at auricular concha is a typical representative of TCM modernization. The taVNS regulates the autonomic nervous system, which shows a good therapeutic effect for the treatment of depression.
OTHERElectro-acupunctureone of the most common acupuncture methods, selecting acupoints based on traditional Chinese medicine theory. It exerts the function to regulate qi and blood circulation and balance Yang and Yin energy inside body.
DRUGCitalopramCitalopram is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class.It has U.S. Food and Drug Administration approval to treat major depression.

Timeline

Start date
2017-11-30
Primary completion
2018-06-30
Completion
2019-06-30
First posted
2017-09-13
Last updated
2017-11-07

Source: ClinicalTrials.gov record NCT03282110. Inclusion in this directory is not an endorsement.